Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. It operates through the following business divisions: Safety Evaluation Research Field, Efficacy Evaluation Research Field, and Analysis Research Field. The Safety Evaluation Research Field division offers studies in areas including general toxicity, local toxicity, reproductive and developmental, genotoxicity, immunotoxicity, carcinogenicity, safety pharmacology, ecotoxicology, histopathology, and hematology. The Efficacy Evaluation Research Field division provides efficacy evaluation and screening materials of medical supplies, health supplements, and cosmetics. The Analysis Research Field division includes the analysis of pharmacokinetics and toxicokinetics, validation, and bioanalysis. The company was founded on August 23, 2000 and is headquartered in Cheongju-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company